Detailed Information on Publication Record
2022
LINEAR AND CONVERGENT SYNTHESIS OF HYDROXAMATE-BASED HISTONE DEACETYLASE INHIBITORS – A COMPARATIVE STUDIES
ONUŠČÁKOVÁ, Magdaléna, Hana PÍŽOVÁ, Tereza KAUEROVÁ, Peter KOLLÁR, Pavel BOBÁĽ et. al.Basic information
Original name
LINEAR AND CONVERGENT SYNTHESIS OF HYDROXAMATE-BASED HISTONE DEACETYLASE INHIBITORS – A COMPARATIVE STUDIES
Authors
ONUŠČÁKOVÁ, Magdaléna (703 Slovakia, guarantor, belonging to the institution), Hana PÍŽOVÁ (203 Czech Republic, belonging to the institution), Tereza KAUEROVÁ (203 Czech Republic, belonging to the institution), Peter KOLLÁR (203 Czech Republic, belonging to the institution) and Pavel BOBÁĽ (703 Slovakia, belonging to the institution)
Edition
Student Scientific Conference PHARM MUNI 2022, 2022
Other information
Language
English
Type of outcome
Prezentace na konferencích
Field of Study
30107 Medicinal chemistry
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14160/22:00126655
Organization unit
Faculty of Pharmacy
ISBN
978-80-280-0105-6
Keywords in English
Mizoroki-Heck reaction_Hydroxamic acid_SAHA_Antiproliferative activity
Změněno: 13/9/2022 14:57, PharmDr. Magdaléna Onuščáková
Abstract
V originále
Histone deacetylase inhibitors (HDACI) represent a relatively new generation of drugs with the ability to affect the expression of specific genes, which can repair controlled proliferation or damaged apoptotic processes in tumor cells. For this reason, HDACIs suggest a promising approach to cancer treatment.
Links
| MUNI/A/1682/2020, interní kód MU |
|